News

Immunai, a New York-based biotech company, announced a $215M Series B, increasing the company’s total funding to date to $295M. The new capital will be used to expand Immunai’s “drug…
Read More...

Boehringer Ingelheim and Thoeris GmbH announce a collaboration and license agreement with the aim to investigate novel first-in-class therapies for patients with urea cycle disorders…
Read More...

Vertex Pharmaceuticals Incorporated and Mammoth Biosciences, a biotech company building the next generation of CRISPR products to cure and detect disease, today announced a new…
Read More...

Teva Pharmaceutical Industries Ltd. and MODAG GmbH announced a strategic collaboration on the exclusive worldwide licensing and development of MODAG's lead compound anle138b and a…
Read More...

Tremeau Pharmaceuticals announced that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Patent Application No. 17/240,446. Once issued, the patent…
Read More...

PTC Therapeutics, Inc. announced that the Brazilian National Health Surveillance Agency, ANVISA (Agência Nacional de Vigilância Sanitária), has approved the expansion of the indication…
Read More...

Xeris Biopharma Holdings, Inc. a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology, neurology, and gastroenterology,…
Read More...

Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration (FDA) has approved Susvimo™ (ranibizumab injection) 100 mg/mL for intravitreal use via…
Read More...

Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. and Clearside Biomedical, Inc. a biopharmaceutical company revolutionizing the delivery of therapies…
Read More...

Merck, known as MSD outside the United States and Canada, announced that the European Commission (EC) has approved KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with chemotherapy…
Read More...

INOVIO a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases,…
Read More...

Mablink Bioscience S.A.S. a biotechnology company developing a pipeline of ADC based on its proprietary PSARlink™ drug-linker technology and Emergence Therapeutics AG, a European…
Read More...

Atreca, Inc. a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human…
Read More...

Pfizer Inc. and BioNTech SE announced topline results from a Phase 3 randomized, controlled trial evaluating the efficacy and safety of a 30-µg booster dose of the Pfizer-BioNTech…
Read More...

Oncodesign, a French biopharmaceutical company specialized in kinase inhibitor research and precision medicine, and TiumBio a company specializing in R&D for rare diseases, have…
Read More...

Biotage AB (publ) has entered into an agreement to acquire all outstanding shares in the privately held company ATDBio Limited based in Oxford and Southampton, UK, for a total purchase…
Read More...

BeiGene, a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide, and…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the U.S. Food and Drug Administration (FDA) has authorized for emergency…
Read More...

Moleculin Biotech, Inc. (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses,…
Read More...

Amgen announced that it has successfully completed its previously announced acquisition of Teneobio, Inc. (Teneobio). Effective as of Oct. 19, 2021, Amgen has acquired all outstanding…
Read More...